- Home
- SOL vs BYSI Comparison
SOL vs BYSI Comparison
Compare SOL & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOL
- BYSI
- Stock Information
- Founded
- SOL 2005
- BYSI 2010
- Country
- SOL United States
- BYSI United States
- Employees
- SOL N/A
- BYSI N/A
- Industry
- SOL Semiconductors
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- SOL Technology
- BYSI Health Care
- Exchange
- SOL Nasdaq
- BYSI Nasdaq
- Market Cap
- SOL 109.2M
- BYSI 99.5M
- IPO Year
- SOL 2008
- BYSI 2017
- Fundamental
- Price
- SOL $2.00
- BYSI $1.73
- Analyst Decision
- SOL Buy
- BYSI
- Analyst Count
- SOL 3
- BYSI 0
- Target Price
- SOL $3.83
- BYSI N/A
- AVG Volume (30 Days)
- SOL 218.5K
- BYSI 19.7K
- Earning Date
- SOL 11-14-2024
- BYSI 01-01-0001
- Dividend Yield
- SOL N/A
- BYSI N/A
- EPS Growth
- SOL N/A
- BYSI N/A
- EPS
- SOL N/A
- BYSI N/A
- Revenue
- SOL $103,577,000.00
- BYSI $1,876,000.00
- Revenue This Year
- SOL $44.70
- BYSI N/A
- Revenue Next Year
- SOL $20.53
- BYSI N/A
- P/E Ratio
- SOL N/A
- BYSI N/A
- Revenue Growth
- SOL 7.56
- BYSI 21.03
- 52 Week Low
- SOL $1.41
- BYSI $0.78
- 52 Week High
- SOL $3.00
- BYSI $4.00
- Technical
- Relative Strength Index (RSI)
- SOL 34.81
- BYSI 28.13
- Support Level
- SOL $2.00
- BYSI $1.85
- Resistance Level
- SOL $2.18
- BYSI $2.10
- Average True Range (ATR)
- SOL 0.15
- BYSI 0.14
- MACD
- SOL -0.06
- BYSI -0.04
- Stochastic Oscillator
- SOL 0.00
- BYSI 0.98
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.